Medical Center Dianamed 2001 EOOD
- Address
- Ulitsa Panayot Hitov 30, 8600 Yambol, Bulgaria
Medical Center Dianamed 2001 EOOD - Infectious Disease and Respiratory Research
Medical Center Dianamed 2001 EOOD is a clinical research facility specializing in infectious disease management and respiratory medicine. The center demonstrates expertise in evaluating novel therapeutic interventions and vaccine safety across diverse patient populations, from pediatric to adult participants. Their research portfolio encompasses both acute infectious conditions and chronic respiratory diseases, positioning them as a versatile clinical trial site.
- Chronic Obstructive Pulmonary Disease (COPD) treatment optimization and exacerbation prevention
- Pediatric vaccine safety studies including varicella immunization protocols
- COVID-19 therapeutic interventions for high-risk populations
- Cardiopulmonary outcomes assessment in respiratory disease management
The center's research activities focus on evaluating combination inhaler therapies for COPD, including triple therapy formulations with budesonide, glycopyrronium, and formoterol, as well as novel monoclonal antibody treatments like tozorakimab for patients with frequent exacerbations. In the infectious disease domain, Dianamed 2001 contributes to critical research on antiviral medications for COVID-19 in non-hospitalized patients and conducts comprehensive safety evaluations of pediatric vaccines administered in combination with standard immunization schedules.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1AstraZeneca AB3active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB4trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medical Center Dianamed 2001 EOOD
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicentre, Parallel-group, Phase IIb, Randomised, Double blind, Placebo-controlled, 4-Arm, 24-Week Study to Evaluate the Efficacy and Safety of AZD6793 Tablets in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (PRESTO). | AstraZeneca AB | Phase II | Recruiting | Sep 2025 | — |
IMP list
lock Showing 1 of 10 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Salbutamol | 2 | Unknown | 2024-02-12 | 2024-07-04 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.